SubHero Banner

Teva – Recall of Valsartan-Containing Products

November 27, 2018 - Teva announced a voluntary, consumer-level recall of all lots of amlodipine/valsartan, and amlodipine/valsartan/hydrochlorothiazide (HCTZ) tablets due to the detection of trace amounts of an unexpected impurity, identified as n-nitrosodiethylamine (NDEA), found in an active pharmaceutical ingredient manufactured by Teva India.

Download PDF